Cargando…
Rapamycin relieves lupus nephritis by regulating TIM-3 and CD4(+)CD25(+)Foxp3(+) Treg cells in an MRL/lpr mouse model
Lupus nephritis (LN) is a severe consequence of systemic lupus erythematosus (SLE) and is an important driver of morbidity and mortality in SLE. Treg cells and TIM-3 play an important role in the pathogenesis of LN. The beneficial effect of rapamycin on LN has been confirmed in both mouse models and...
Autores principales: | Gao, Yan-fang, Fan, Xiu-zhao, Li, Rong-shan, Zhou, Xiao-shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896989/ https://www.ncbi.nlm.nih.gov/pubmed/36817267 http://dx.doi.org/10.5114/ceji.2022.118778 |
Ejemplares similares
-
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
por: Wang, Huixia, et al.
Publicado: (2019) -
Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment
Publicado: (1991) -
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
por: Shi, Yu, et al.
Publicado: (2019) -
CD4(+)CD25(-)Foxp3(+) T cells: a marker for lupus nephritis?
por: Bonelli, Michael, et al.
Publicado: (2014) -
Chlorogenic Acid Relieves the Lupus Erythematosus-like Skin Lesions and Arthritis in MRL/lpr Mice
por: Wang, Ruxuan, et al.
Publicado: (2022)